University Hospital Ghent

Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Vascular supply of the metacarpophalangeal joint (2022) Baksa G, Czeibert K, Sharp V, Handschuh S, Gyebnar J, Barany L, Benis S, et al. Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution How Well Does Ultrasound-assessed Synovitis in Reduced Joint Sets Predict the Response to Secukinumab in Patients with Active Psoriatic Arthritis and Inadequate Response to Conventional DMARDs? - Exploratory Results from a Phase 3b Study (2022) D'Agostino MA, Conaghan PG, Gaillez C, Naredo E, Mandl P, Carron P, Senolt L, et al. Conference contribution A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution Pathway to assess severe primary IGF-1 deficiency diagnosis in a real-life setting: data from the Global Increlex (R) Registry (2022) Bang P, Polak M, Bossowski A, De Schepper J, Sert C, Perrot V, Wölfle J Conference contribution Definition, diagnosis and clinical management of non-obstructive kidney dysplasia: a consensus statement by the ERKNet Working Group on Kidney Malformations (2022) Kohl S, Avni FE, Boor P, Capone V, Clapp WL, De Palma D, Harris T, et al. Journal article CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE. (2022) Lescoat A, Huang S, Carreira P, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al. Conference contribution PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE (2022) Sarbu AC, Guler S, Stadler O, Allanore Y, Bernardino V, Distler J, Gabrielli A, et al. Conference contribution REDUCED JOINT SYNOVITIS ASSESSMENT VERSUS THE GLOBAL EULAR OMERACT SYNOVITIS SCORE (GLOESS) TO PREDICT THE RESPONSE TO SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO CONVENTIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: EXPLORATORY RESULTS FROM THE ULTIMATE TRIAL (2022) D'Agostino MA, Boers M, Schett G, Conaghan PG, Naredo E, Mandl P, Carron P, et al. Conference contribution